Who has invested in Biobeat?

Ally Bridge Group, OrbiMed Advisors, Elevage Medical Technologies are named among the investors backing Biobeat.

Biobeat Funding: $58M Raised, Series B (2025)

Biobeat funding overview

Biobeat is based in Petah Tikva, Israel. Biobeat has raised $58M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2025. The round record for Biobeat runs through 2025; nothing later has been disclosed. Investors on record include Ally Bridge Group, OrbiMed Advisors, Elevage Medical Technologies. 3 distinct backers are named across the disclosed rounds.

Biobeat at a glance

Total raised: $58M
Latest round: Series B
Latest round date: August 2025
Headquarters: Petah Tikva, Israel
Notable investors: Ally Bridge Group, OrbiMed Advisors, Elevage Medical Technologies

Frequently asked about Biobeat funding

How much has Biobeat raised?: Biobeat has raised $58M in total disclosed funding across the rounds on record.
Who has invested in Biobeat?: Ally Bridge Group, OrbiMed Advisors, Elevage Medical Technologies are named among the investors backing Biobeat.
What was the latest Biobeat funding round?: The most recent disclosed round is a Series B, announced in August 2025.
Where is Biobeat based?: Biobeat is based in Petah Tikva, Israel.
When did Biobeat last raise?: The last disclosed Biobeat round closed in August 2025 at Series B.

Round data for Biobeat is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Petah Tikva and backer lists below.

Biobeat Funding: $58M Raised, Series B (2025)

Biobeat funding overview

Biobeat at a glance

Frequently asked about Biobeat funding

Companies related to Biobeat (25)

Browse related funding lists (5)